Dr Christopher Benton speaks to ecancer in online video interview about the management and treatment of patients with acute lymphoblastic leukaemia (ALL) during the COVID-19 pandemic.
He highlights the main treatment approaches for these patients, and believes they should be managed according to their stage of treatment. These include newly-diagnosed patients on intensive therapy, patients on maintenance therapy, and those who have completed treatment.
Dr Benton also discusses the role of telemedicine, which has been heavily utilised during the course of the pandemic.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.